The objective of these experiments was to explore the possibility of preventing the rapid destruction and removal from circulation of human erythrocytes transfused into rats. Significant prolongation of heterologous erythrocyte survival could pave the way for development of a system that might be useful in studies of blood preservation. There also is the possibility that certain aspects of these studies could provide the basis for modification of complement dependent hemolytic disorders in man.
Erythrocytes in heterologous serum in vitro may undergo rapid lysis due to the presence of complement-binding "natural" antibodies in serum.' The lytic process probably involves sequential activation of all nine components of complement.' The extremely short intravascular survival of heterologous erythrocytes is the result not only of hemolysis due to complement-binding antibody but also of the rapid removal of the sensitized erythrocytes by the cells of the reticuloendothelial system (RES), especially those of the liver and spleen. ' In order to prolong the survival of human erythrocytes in the rat, the third component of complement, C3, which is essential for hemolysis, was inhibited through the administration of a cobra venom factor (CVF).' This factor also is a striking inhibitor of phagocytosis,' but has no effect on agglutination of red cells by immune or "natural" antibody. Further improvement in erythrocyte survival was achieved when CVF was combined with either surgical splenectomy or pretreatment with ethyl plamitate (EP) which both blocks the RES and produces functional splenic ablation (medical splenectomy), but has no known effect on hemolytic complement.'
MATERIALS AND METHODS
The CVF from venom of Naja naja was isolated as a non-toxic 6.6 S protein by chromatographic techniques already described for a similar, if not 
DISCUSSION
These observations demonstrate the effectiveness of the sequential blocking of certain factors responsible for the in vivo destruction of incompatible heterologous erythrocytes. The precise mechanisms through which erythrocyte survival is prolonged is uncertain, but information concerning the tissue effects of EP and CVF provides the basis for some reasonable speculation. Presumably, the combination of intravascular hemolysis and RES removal of heavily damaged erythrocytes was of such magnitude that splenectomy alone had no effect. CVF-induced reduction in erythrocyte surface damage and intravascular hemolysis, however, resulted in -significant improvement in erythrocyte survival. EP alone induced sufficient RES blockade and It seems likely that future results will be improved through use of multiple blocking agents combined with techniques designed to inhibit agglutination and phagocytosis in animals with greater erythrocyte compatibility and more complete suppression of C3 or other components of complement that are essential for hemolysis. The C3 activity of guinea pigs is depressed for periods of from 3 to 5 days following a single injection of CVF.8 The possibility of developing a practical system that might permit survival of either heterologous or incompatible homologous erythrocytes for periods of several days or more does not seem unreasonable. Inhibition of autoimmune hemolytic mechanisms with CVF is an additional area of considerable promise.
SUMMARY
A fortyfold enchancement of human erythrocyte T Y2 survival in the rat was achieved through the combination of RES blockade, chemically induced splenic ablation and inactivation of the third component of complement following injection of ethyl palmitate and a factor isolated from cobra venom.
